Induction of multipotency in umbilical cord-derived mesenchymal stem cells cultivated under suspension conditions |
| |
Authors: | Fatemeh Amiri Raheleh Halabian Morteza Salimian Mohammad Ali Shokrgozar Masoud Soleimani Ali Jahanian-Najafabadi Mehryar Habibi Roudkenar |
| |
Affiliation: | 1. Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran 2. Applied Microbiology Research Center, Medical Science of Baqiyatallah University, Tehran, Iran 3. Department of Medical Laboratory, Kashan University of Medical Sciences and Health, Kashan, Iran 4. National Cell Bank, Pasteur Institute of Iran, Tehran, Iran 5. Department of Hematology, School of Medical Sciences, Tarbiat Modarres University, Tehran, Iran 6. Department of Pharmaceutical Biotechnology and Bioinformatics Research Center, School of Pharmacy, Isfahan University of Medical Sciences and Health Services, Isfahan, Iran
|
| |
Abstract: | ![]() Due to the limitations in the clinical application of embryonic stem cells (ESC) and induced pluripotent stem cells, mesenchymal stem cells (MSCs) are now much more interesting for cell-based therapy. Although MSCs have several advantages, they are not capable of differentiating to all three embryonic layers (three germ layers) without cultivation under specific induction media. Hence, improvement of MSCs for cell therapy purposes is under intensive study now. In this study, we isolated MSCs from umbilical cord tissue at the single-cell level, by treatment with trypsin, followed by cultivation under suspension conditions to form a colony. These colonies were trypsin resistant, capable of self-renewal differentiation to the three germ layers without any induction, and they were somewhat similar to ESC colonies. The cells were able to grow in both adherent and suspension culture conditions, expressed both the MSCs markers, especially CD105, and the multipotency markers, i.e., SSEA-3, and had a limited lifespan. The cells were expanded under simple culture conditions at the single-cell level and were homogenous. Further and complementary studies are required to understand how trypsin-tolerant mesenchymal stem cells are established. However, our study suggested non-embryonic resources for future cell-based therapy. |
| |
Keywords: | Umbilical cord-derived mesenchymal stem cell Multipotency markers Suspension cultivation Poly-HEMA Trypsin treatment |
本文献已被 SpringerLink 等数据库收录! |
|